Related references
Note: Only part of the references are listed.Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Yin Yang 1 Is a Novel Regulator of Pulmonary Fibrosis
Xin Lin et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Integrating mechanisms of pulmonary fibrosis
Thomas A. Wynn
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Expression of Matrix Metalloproteinase-13 Is Controlled by IL-13 via PI3K/Akt3 and PKC-δ in Normal Human Dermal Fibroblasts
Chikako Moriya et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Phosphoinositide 3-kinase γ plays a critical role in bleomycin-induced pulmonary inflammation and fibrosis in mice
Remo C. Russo et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
PPAR-γ Ligands Repress TGFβ-Induced Myofibroblast Differentiation by Targeting the PI3K/Akt Pathway: Implications for Therapy of Fibrosis
Ajit A. Kulkarni et al.
PLOS ONE (2011)
Therapeutic Efficacy of Cintredekin Besudotox (IL13-PE38QQR) in Murine Lung Fibrosis Is Unaffected by Immunity to Pseudomonas aeruginosa Exotoxin A
Rogerio S. Rosada et al.
PLOS ONE (2010)
Toll-like receptor 4 mediates lipopolysaccharide-induced collagen secretion by phosphoinositide3-kinase-akt pathway in fibroblasts during acute lung injury
ZhengYu He et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2009)
Pulmonary fibrosis: pathogenesis, etiology and regulation
M. S. Wilson et al.
MUCOSAL IMMUNOLOGY (2009)
Interleukin-13 acts as an apoptotic effector on lung epithelial cells and induces pro-fibrotic gene expression in lung fibroblasts
A. Borowski et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2008)
Protein Kinase Inhibitors in the Treatment of Pulmonary Fibrosis
Sylvie Garneau-Tsodikova et al.
CURRENT MEDICINAL CHEMISTRY (2008)
IL-13 Signaling via IL-13Rα2 Induces Major Downstream Fibrogenic Factors Mediating Fibrosis in Chronic TNBS Colitis
Stefan Fichtner-Feigl et al.
GASTROENTEROLOGY (2008)
Current and emerging drugs for idiopathic pulmonary fibrosis
Mehrnaz Gharaee-Kermani et al.
EXPERT OPINION ON EMERGING DRUGS (2007)
Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition
E. K-H Han et al.
ONCOGENE (2007)
Semaphorin 7A plays a critical role in TGF-β1-induced pulmonary fibrosis
Hye-Ryun Kang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
'Rituximab-induced inhibition of antiapoptotic cell survival pathways: implications in chemo/immunoresistance, rituximab unresponsiveness, prognostic and novel therapeutic interventions'
B. Bonavida
ONCOGENE (2007)
Induction of IL-13 triggers TGF-β1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis
Stefan Fichtner-Feigl et al.
JOURNAL OF IMMUNOLOGY (2007)
Combinatorial activation of FAK and AKT by transfonning growth factor-β1 confers an anoikis-resistant phenotype to myofibroblasts
Jeffrey C. Horowitz et al.
CELLULAR SIGNALLING (2007)
IL-13 signaling through the IL-13 alpha 2 receptor is involved in induction of TGF-beta 1 production and fibrosis
S Fichtner-Feigl et al.
NATURE MEDICINE (2006)
IL-4 and IL-13 induce protection of porcine endothelial cells from killing by human complement and from apoptosis through activation of a phosphatidylinositide 3-kinase/Akt pathway
JF Grehan et al.
JOURNAL OF IMMUNOLOGY (2005)
Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury
R Vittal et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-β1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor
JC Horowitz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
IL-13 activates a mechanism of tissue fibrosis that is completely TGF-β independent
M Kaviratne et al.
JOURNAL OF IMMUNOLOGY (2004)
Idiopathic pulmonary fibrosis: current understanding of the pathogenesis and the status of treatment
N Khalil et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2004)
Mammalian target of rapamycin positively regulates collagen type I production via a phosphatidylinositol 3-kinase-independent pathway
D Shegogue et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Potential action of IL-4 and IL-13 as fibrogenic factors on lung fibroblasts in vitro
A Saito et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2003)
Therapeutic attenuation of pulmonary fibrosis via targeting of IL-4- and IL-13-responsive cells
C Jakubzick et al.
JOURNAL OF IMMUNOLOGY (2003)
Myofibroblast differentiation by transforming growth factor-β1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase
VJ Thannickal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1
CG Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Regulation of α-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts
SG Roy et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2001)
Schistosome infection of transgenic mice defines distinct and contrasting pathogenic roles for IL-4 and IL-13: is a profibrotic agent
PG Fallon et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
